David M. Markusic

3.0k citations

54 papers · 2.4k indexed · h-index 26

Impact in

Genetics top 1%
- Virus-based gene therapy research
Hematology top 5%
- Hemophilia Treatment and Research

Papers in

Genetics 39
- Virus-based gene therapy research 38
Infectious Diseases 13
- Viral gastroenteritis research and epidemiology 11

Co-authors: Roland W. Herzog Brad E. Hoffman Ashley T. Martino George Q. Perrin Katherine A. High Sandeep Kumar Moanaro Biswas Irene Zolotukhin
Journals: Molecular Therapy — Methods & Clinical Development (9 papers)Blood (8 papers)Molecular Therapy (6 papers)Human Gene Therapy (4 papers)PLoS ONE (3 papers)
Partner nations: United States Netherlands India

In The Last Decade

David M. Markusic

54 papers receiving 2.4k citations

Peers

Countries citing papers authored by David M. Markusic

Since Specialization

Citations

This map shows the geographic impact of David M. Markusic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Markusic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Markusic more than expected).

Fields of papers citing papers by David M. Markusic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Markusic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Markusic. The network helps show where David M. Markusic may publish in the future.

Co-authors

The 25 scholars most cited alongside David M. Markusic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David M. Markusic Line = papers co-authored together David M. Markusic links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Inhibition of IFNAR-JAK signaling enhances tolerability and transgene expression of systemic non-viral DNA delivery Molecular Therapy — Nucleic Acids ·D. S. Bertram, Thaís B. Bertolini, Raisa Tahiyah, Mustafa N. Yazicioglu, David M. Markusic, Fatemeh Ebrahimi-Tazangi, Joan Wicks, Ali Nahvi, Roland W. Herzog, Matthew C. Walsh, Pedro J. Cejas, Sean M. Armour	2025	2
2	Complement System Response to Adeno-Associated Virus Vector Gene Therapy Human Gene Therapy ·Elizabeth Kropf, David M. Markusic, Judha Herdanta, Federico Mingozzi, Klaudia Kuranda	2024	15
3	Viral Vector Based Immunotherapy for Peanut Allergy Viruses ·Ю. М. Чинючин, Roland W. Herzog, 宋立中, Z Wang, Joan M. Cook‐Mills, Henry Daniell, David M. Markusic	2024	2
4	Comprehensive Comparison of AAV Purification Methods: Iodixanol Gradient Centrifugation vs. Immuno-Affinity Chromatography PubMed ·Davies Corresp, Patrick L. Mulcrone, Dylan Frabutt, Junping Zhang, Matthew Chrzanowski, Sreevani Arisa, Eric Schneiderloechner, Xin Li, Moanaro Biswas, David M. Markusic, Roland W. Herzog, Weidong Xiao	2023	10
5	Coagulation factor IX gene transfer to non-human primates using engineered AAV3 capsid and hepatic optimized expression cassette Molecular Therapy — Methods & Clinical Development ·Sandeep Kumar, Jun Xie, Bibiana Centro, Ningyi Zhang, Steeven Marín Burgos, Harrison C. Brown, Alok Srivastava, David M. Markusic, Christopher B. Doering, H. Trent Spencer, Arun Srivastava, Guangping Gao, Roland W. Herzog	2021	12
6	Development of a Clinical Candidate AAV3 Vector for Gene Therapy of Hemophilia B Human Gene Therapy ·Harrison C. Brown, Christopher B. Doering, Roland W. Herzog, Chen Ling, David M. Markusic, H. Trent Spencer, Alok Srivastava, Arun Srivastava, (unknown), (unknown)	2020	23
7	Immunology of Gene and Cell Therapy Molecular Therapy ·David M. Markusic, Ashley T. Martino, Christopher D. Porada, Thierry VandenDriessche	2020	5
8	Adeno-Associated Virus D-Sequence-Mediated Suppression of Expression of a Human Major Histocompatibility Class II Gene: Implications in the Development of Adeno-Associated Virus Vectors for Modulating Humoral Immune Response Human Gene Therapy ·Hyung‐Joo Kwon, Keyun Qing, Selvarangan Ponnazhagan, Xu-Shan Wang, David M. Markusic, Rogoum Tedebaye, Sanford L. Boye, Arun Srivastava	2020	5
9	Update on clinical gene therapy for hemophilia PMC ·George Q. Perrin, Roland W. Herzog, David M. Markusic	2019	5
10	AAV-Mediated Gene Delivery to the Liver: Overview of Current Technologies and Methods Methods in molecular biology ·Hazel Nasiphi Moya, Roland W. Herzog, David M. Markusic	2019	31
11	Update on clinical gene therapy for hemophilia Blood ·George Q. Perrin, Roland W. Herzog, David M. Markusic	2018	132
12	An Immune-Competent Murine Model to Study Elimination of AAV-Transduced Hepatocytes by Capsid-Specific CD8+ T Cells Molecular Therapy — Methods & Clinical Development ·Hazel Nasiphi Moya, Damien Marsic, Roland W. Herzog, Sergei Zolotukhin, David M. Markusic	2017	17
13	Clinical development of gene therapy: results and lessons from recent successes Molecular Therapy — Methods & Clinical Development ·Sandeep Kumar, David M. Markusic, Moanaro Biswas, Katherine A. High, Roland W. Herzog	2016	173
14	Unique Roles of TLR9- and MyD88-Dependent and -Independent Pathways in Adaptive Immune Responses to AAV-Mediated Gene Transfer Journal of Innate Immunity ·Geoffrey L. Rogers, Masataka Suzuki, Irene Zolotukhin, David M. Markusic, Laurence Morel, Brendan Lee, Hildegund C.J. Ertl, Roland W. Herzog	2015	72
15	Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell–dependent induction of CD4+CD25+FoxP3+ Treg Blood ·Moanaro Biswas, Debalina Sarkar, Sandeep Kumar, Sushrusha Nayak, Geoffrey L. Rogers, David M. Markusic, Gongxian Liao, Cox Terhorst, Roland W. Herzog	2015	58
16	Ex vivo expanded autologous polyclonal regulatory T cells suppress inhibitor formation in hemophilia Molecular Therapy — Methods & Clinical Development ·Debalina Sarkar, Moanaro Biswas, Gongxian Liao, Howard R. Seay, George Q. Perrin, David M. Markusic, Brad E. Hoffman, Todd M. Brusko, Cox Terhorst, Roland W. Herzog	2014	58
17	Separating Lentiviral Vector Injection and Induction of Gene Expression in Time, Does Not Prevent an Immune Response to rtTA in Rats PLoS ONE ·David M. Markusic, Dirk R. de Waart, Jurgen Seppen	2010	14
18	High-efficiency Transduction and Correction of Murine Hemophilia B Using AAV2 Vectors Devoid of Multiple Surface-exposed Tyrosines Molecular Therapy ·David M. Markusic, Roland W. Herzog, George Aslanidi, Brad E. Hoffman, Baozheng Li, Mengxin Li, Giridhara R. Jayandharan, Chen Ling, Irene Zolotukhin, Wenqin Ma, Sergei Zolotukhin, Arun Srivastava, Zhong Li	2010	111
19	Doxycycline Regulated Lentiviral Vectors Methods in molecular biology ·David M. Markusic, Jurgen Seppen	2009	5
20	Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter Nucleic Acids Research ·David M. Markusic	2005	63

About David M. Markusic

David M. Markusic is a scholar working on Genetics, Infectious Diseases, Oncology, Immunology and Allergy and Molecular Biology, having authored 54 papers that have together received 2.4k indexed citations. Recurring topics across this work include Virus-based gene therapy research (38 papers), CAR-T cell therapy research (18 papers), CRISPR and Genetic Engineering (14 papers), RNA Interference and Gene Delivery (12 papers), Viral gastroenteritis research and epidemiology (11 papers), Viral Infectious Diseases and Gene Expression in Insects (8 papers), Hemophilia Treatment and Research (5 papers) and Viral Infections and Immunology Research (4 papers). The work is most often cited by research in Genetics (1.4k citations), Hematology (298 citations), Oncology (641 citations), Molecular Biology (1.5k citations) and Clinical Biochemistry (146 citations). David M. Markusic has collaborated with scholars based in United States, Netherlands and India. Frequent co-authors include Roland W. Herzog, Brad E. Hoffman, Ashley T. Martino, George Q. Perrin, Katherine A. High, Sandeep Kumar, Moanaro Biswas, Irene Zolotukhin, Cox Terhorst and Brandon K. Sack. Their work appears in journals such as Molecular Therapy — Methods & Clinical Development, Blood, Molecular Therapy, Human Gene Therapy and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact